Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- ILa | -.--% | -0,67% | -16,62% |
08/05 | Indaptus Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 | CI |
14/03 | Les plus fortes hausses du prémarché | MT |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Newman
FOU | Founder | 68 | 24/02/21 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 03/08/21 |
Nir Sassi
DFI | Director of Finance/CFO | 48 | 01/07/21 |
Roger Waltzman
CTO | Chief Tech/Sci/R&D Officer | 56 | 07/08/23 |
Walt Linscott
COO | Chief Operating Officer | 63 | 01/07/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
William Hayes
BRD | Director/Board Member | 58 | 03/08/21 |
Jeffrey Meckler
CEO | Chief Executive Officer | 57 | 03/08/21 |
Robert Martell
BRD | Director/Board Member | 61 | 13/01/23 |
Hila Karah
BRD | Director/Board Member | 55 | 01/07/21 |
Michael Newman
FOU | Founder | 68 | 24/02/21 |
Roger Pomerantz
CHM | Chairman | 67 | 01/08/21 |
Director/Board Member | 71 | 01/07/21 | |
Mark Gilbert
BRD | Director/Board Member | 63 | 01/11/21 |
Coordonnées société
Secteur
- Bourse
- Actions
- Action INDP
- Action NTEC
- Société Intec Pharma Ltd